{"id":"W4404480970","doi":"10.1016/s2468-1253(24)00317-0","title":"Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial","year":2024,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Vedolizumab; Medicine; Placebo; Crohn's disease; Double blind; Internal medicine; Surgery; Disease; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001427528,0.001683032,0.004252702,0.0004371323,0.0004333641,0.001199119,0.00093864,0.002581997,0.006714871],"category_scores_gemma":[0.001846581,0.000787278,0.00238956,0.0004498441,0.001004557,0.001053317,0.000457307,0.002685569,0.001054315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006120714,"about_ca_system_score_gemma":0.0006356876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009832643,"about_ca_topic_score_gemma":0.001705653,"domain_scores_codex":[0.9994259,0.0002550014,0.00005412836,0.0001162033,0.00004899407,0.00009989016],"domain_scores_gemma":[0.9993314,0.0002461969,0.0001607083,0.000049497,0.00005180873,0.0001604858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9838345,0.00104381,0.0001836884,0.001906355,0.001265089,0.00003005783,0.00002567572,0.0001014715,0.001584595,0.00008811904,0.0005615345,0.009375001],"study_design_scores_gemma":[0.9835663,0.0143449,0.0007604224,0.0000673934,0.0006160011,0.00002125221,0.0000128593,0.00009339592,0.0001295597,0.00005839882,0.0003193618,0.00001004531],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9403635,0.04630376,0.001033624,0.001714372,0.002788327,0.003101571,0.001557199,0.0002244086,0.002913122],"genre_scores_gemma":[0.9659497,0.01630199,0.002139067,0.002339149,0.001283988,0.004711039,0.001309811,0.00003659201,0.005928735],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006714871,"threshold_uncertainty_score":0.0224635,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01728513506448125,"score_gpt":0.2875952542572869,"score_spread":0.2703101191928057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}